Mission Statement, Vision, & Core Values of Amgen Inc. (AMGN)

Are you curious about what drives one of the world's leading biotechnology companies? In 2024, Amgen's total revenue reached $33.4 billion, a 19% increase from 2023, fueled by a 23% surge in product sales volume. But beyond the numbers, what are the guiding principles that shape its culture and strategic direction?

Understanding a company's mission, vision, and core values provides critical insights into its long-term goals and how it operates. What exactly does Amgen aim to achieve, and what values underpin its pursuit of innovation and patient care?

Dive in to explore the core tenets that define Amgen, influencing everything from its scientific endeavors to its relationships with patients, employees, and shareholders. Discover how these principles contribute to its position as a leader in the biotechnology industry.

Amgen Inc. (AMGN) An Overview of

Amgen Inc. (AMGN) is a global biotechnology company dedicated to discovering, developing, manufacturing, and delivering innovative human therapeutics. Since its founding in 1980, Amgen has pioneered advancements in biotechnology, bringing to market a range of products that address serious illnesses. The company focuses on areas of high unmet medical need, leveraging its expertise in molecular biology and genetics to unlock the potential of new medicines. As of April 2025, Amgen continues to expand its portfolio and global reach, driven by a commitment to improving patient outcomes worldwide.

In its latest financial reports, Amgen has demonstrated strong financial performance, marked by record-breaking revenue and growth in key markets. The company's success is significantly attributed to the robust sales of its main products, which have shown substantial growth year-over-year. For example, in the 2024 fiscal year, Amgen reported a revenue of $32.6 billion. Key products driving this revenue included:

• Prolia: $3.9 billion, up 12%
• Repatha: $1.7 billion, up 25%
• Otezla: $2.5 billion, up 3%

These figures underscore Amgen's ability to innovate and commercialize products effectively, reinforcing its position as a leader in the biotechnology industry.

Amgen stands as a leading company in the biotechnology sector, renowned for its scientific rigor, innovative therapies, and commitment to patient care. Its success is built on a foundation of cutting-edge research, strategic acquisitions, and a global presence that allows it to deliver medicines to patients in need worldwide. To understand more about why Amgen is so successful, explore: Amgen Inc. (AMGN): History, Ownership, Mission, How It Works & Makes Money

Amgen Inc. (AMGN) Mission Statement

Amgen's mission statement is 'to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or save lives.' This statement underscores the company's focus on leveraging scientific advancements to develop innovative treatments for serious illnesses.

Here's a breakdown of the core components of Amgen's mission statement:

Serving Patients

At the heart of Amgen's mission is a commitment to serving patients. This patient-centric approach is reflected in the company's efforts to address unmet medical needs and improve patient outcomes. Amgen focuses on developing therapies for serious illnesses where there is a significant need for better treatment options.

Examples of Amgen’s patient-focused initiatives include:

• Developing innovative medicines for diseases like cancer, cardiovascular disease, and osteoporosis.
• Providing patient support programs to help individuals manage their conditions and access necessary treatments.
• Collaborating with patient advocacy groups to raise awareness and improve care for specific diseases.

Transforming the Promise of Science and Biotechnology

Amgen emphasizes the importance of translating scientific discoveries and biotechnological advancements into tangible therapies. This involves investing in research and development to identify promising drug candidates and conduct clinical trials to evaluate their safety and efficacy. The company's focus on innovation is driven by a desire to push the boundaries of medical science and develop treatments that can make a meaningful difference in patients' lives.

Amgen's research and development efforts are supported by substantial investments. For example, in 2024, Amgen's R&D expenses were $5.2 billion, reflecting its commitment to innovation.

Examples of Amgen’s focus on science and biotechnology include:

• Utilizing advanced technologies like genomics and proteomics to identify new drug targets.
• Developing novel therapeutic modalities such as biosimilars and gene therapies.
• Partnering with academic institutions and other research organizations to accelerate the pace of scientific discovery.

Restoring Health or Saving Lives

The ultimate goal of Amgen's mission is to develop therapies that can restore health or save lives. This reflects the company's commitment to addressing serious illnesses and improving patient outcomes. Amgen focuses on developing treatments that can either cure diseases, alleviate symptoms, or extend life expectancy.

Examples of Amgen’s efforts to restore health or save lives include:

• Developing therapies that have significantly improved survival rates for certain types of cancer.
• Creating treatments that can prevent or delay the onset of serious cardiovascular events.
• Providing medicines that can help patients manage chronic conditions and improve their quality of life.

Amgen's commitment to its mission is evident in its financial performance and its impact on global health. In 2024, Amgen reported total revenues of $32.6 billion, reflecting the demand for its innovative therapies.

To gain more insights into Amgen's financial stability and investment potential, consider exploring Breaking Down Amgen Inc. (AMGN) Financial Health: Key Insights for Investors.

Amgen Inc. (AMGN) Vision Statement of

Amgen's mission is 'To serve patients by transforming the promise of science and biotechnology into medicines that have the power to restore health or save lives.' This mission guides Amgen's strategic decisions and underscores its commitment to addressing serious illnesses. As of the fiscal year 2024, Amgen invested heavily in Research and Development (R&D), spending $5.2 billion to drive innovation and expand its pipeline of potential new medicines. This investment reflects the company's dedication to translating scientific breakthroughs into tangible benefits for patients.

Amgen's unwavering focus on patients is evident in its operational strategies and financial allocations. In 2024, Amgen reported total revenues of $32.6 billion, a portion of which is reinvested into patient support programs and initiatives aimed at improving access to its medications. This commitment extends beyond drug development to encompass a holistic approach to patient care.

Transforming Science and Biotechnology

Amgen's vision is deeply rooted in its ability to transform scientific discoveries into practical medical solutions. This involves not only identifying promising scientific advancements but also navigating the complex process of drug development, clinical trials, and regulatory approvals. In 2024, Amgen's R&D efforts led to several significant milestones, including the advancement of multiple pipeline candidates into late-stage clinical trials. These advancements underscore Amgen's capacity to translate scientific promise into tangible medical progress.

Amgen embraces advanced technologies and innovative approaches to enhance its drug discovery and development processes. This includes leveraging data analytics, artificial intelligence, and precision medicine techniques to identify potential drug targets and optimize treatment strategies. The company's commitment to innovation is reflected in its collaborations with leading research institutions and technology companies, fostering a dynamic ecosystem of scientific exchange and discovery.

Medicines That Restore Health or Save Lives

Amgen's ultimate goal is to develop and deliver medicines that have a profound impact on patients' lives. This includes addressing a wide range of serious illnesses, from cancer and cardiovascular disease to osteoporosis and kidney disease. In 2024, Amgen's portfolio of marketed products generated $32.6 billion in revenue, providing essential treatments to millions of patients worldwide. These medicines play a critical role in restoring health, improving quality of life, and, in many cases, saving lives.

Amgen is committed to ensuring that its medicines are accessible to patients who need them. This involves working with healthcare providers, payers, and patient advocacy groups to navigate the complexities of healthcare systems and reimbursement pathways. In 2024, Amgen provided significant financial assistance to patients through its patient assistance programs, helping to alleviate the financial burden of treatment and ensure that patients have access to the medicines they need.

Examples of how Amgen delivers medicines that restore health or save lives include:

• Oncology: Developing therapies that target specific cancer cells, improving survival rates and quality of life for cancer patients.
• Cardiovascular Disease: Creating medications that lower cholesterol levels, reducing the risk of heart attacks and strokes.
• Bone Health: Providing treatments that strengthen bones and prevent fractures in patients with osteoporosis.
• Nephrology: Offering therapies that manage kidney disease and improve outcomes for patients with chronic kidney conditions.

Amgen's commitment to serving patients is deeply ingrained in its corporate culture and values. This commitment is reflected in the company's mission statement, strategic priorities, and day-to-day operations. By focusing on transforming the promise of science and biotechnology into medicines that have the power to restore health or save lives, Amgen strives to make a meaningful difference in the lives of patients worldwide.

Amgen Inc. (AMGN) Core Values of

At Company, a leading biotechnology company, core values are integral to its mission of serving patients. These values guide the company's actions, decisions, and overall culture, reflecting a commitment to innovation, ethics, and patient-centricity. The values are not merely aspirational but are embedded in day-to-day operations and strategic initiatives. You can learn more about Company’s history and mission Amgen Inc. (AMGN): History, Ownership, Mission, How It Works & Makes Money.

Be Science-Based

Company places a high value on being science-based, emphasizing the importance of rigorous scientific inquiry and data-driven decision-making. This commitment is crucial in the biotechnology industry, where advancements depend on research and development. The company's approach to drug discovery and development relies heavily on scientific evidence to ensure the safety and efficacy of its products.

Examples of how Company demonstrates this value include:

• Investing heavily in Research and Development (R&D): In 2024, Company invested $5.2 billion in R&D to advance its pipeline of innovative medicines.
• Conducting rigorous clinical trials: Company adheres to strict scientific protocols and regulatory standards in its clinical trials to ensure the reliability of its data. For instance, the company's clinical trials for its biosimilars follow guidelines set by regulatory agencies such as the FDA and EMA.
• Publishing scientific findings: Company actively publishes its research findings in peer-reviewed journals, contributing to the scientific community's knowledge base. In 2024, Company scientists published over 500 scientific papers.

Compete Intensely and Win

Company fosters a culture of intense competition with a focus on achieving success in the biopharmaceutical market. This value drives the company to outperform its competitors and deliver innovative solutions to patients. Competing intensely involves setting ambitious goals, executing strategies effectively, and continuously improving performance.

Examples of how Company demonstrates this value include:

• Expanding its product portfolio: Company actively seeks to expand its portfolio through strategic acquisitions and collaborations. In 2024, Company completed the acquisition of Horizon Therapeutics for $27.8 billion, adding several key products to its portfolio.
• Increasing market share: Company strives to increase its market share through effective marketing and sales strategies. In 2024, Company reported total revenues of $32.6 billion, reflecting a 6% increase compared to the previous year.
• Driving operational efficiency: Company focuses on improving its operational efficiency to reduce costs and enhance profitability. In 2024, Company implemented various cost-saving initiatives, resulting in $500 million in savings.

Create Value for Patients, Staff, and Stockholders

Company is dedicated to creating value for its key stakeholders: patients, staff, and stockholders. This value reflects the company's commitment to delivering innovative medicines, providing a rewarding work environment, and generating financial returns for its investors. Balancing the interests of these stakeholders is essential for long-term success and sustainability.

Examples of how Company demonstrates this value include:

• Developing innovative medicines: Company invests in R&D to develop innovative medicines that address unmet medical needs. In 2024, Company launched several new products, including a novel therapy for cardiovascular disease.
• Providing employee benefits and development opportunities: Company offers competitive salaries, comprehensive benefits, and opportunities for professional development. In 2024, Company invested $50 million in employee training and development programs.
• Delivering financial returns to stockholders: Company strives to deliver consistent financial returns to its stockholders through revenue growth and profitability. In 2024, Company returned $4.0 billion to stockholders through dividends and share repurchases.

Be Ethical

Company emphasizes the importance of ethical conduct in all its operations. This value reflects the company's commitment to integrity, transparency, and compliance with laws and regulations. Maintaining high ethical standards is crucial for building trust with stakeholders and ensuring the company's long-term reputation.

Examples of how Company demonstrates this value include:

• Adhering to compliance standards: Company has a robust compliance program that ensures adherence to laws, regulations, and ethical guidelines. In 2024, Company conducted over 10,000 compliance audits and training sessions.
• Promoting transparency: Company is committed to transparency in its interactions with stakeholders, including patients, healthcare professionals, and regulatory agencies. Company publishes detailed information about its clinical trials and product safety data.
• Upholding ethical business practices: Company prohibits bribery, corruption, and other unethical business practices. Company has a code of conduct that outlines ethical standards for all employees.

Trust and Respect Each Other

Company promotes a culture of trust and respect among its employees. This value recognizes the importance of teamwork, collaboration, and mutual support in achieving the company's goals. Creating a positive and inclusive work environment is essential for attracting and retaining top talent.

Examples of how Company demonstrates this value include:

• Fostering diversity and inclusion: Company is committed to fostering a diverse and inclusive work environment where all employees feel valued and respected. In 2024, Company launched several initiatives to promote diversity and inclusion, including employee resource groups and mentorship programs.
• Encouraging teamwork and collaboration: Company encourages teamwork and collaboration through cross-functional teams and collaborative workspaces. Company provides employees with opportunities to work together on projects and initiatives.
• Providing feedback and recognition: Company provides employees with regular feedback and recognition for their contributions. Company has a performance management system that encourages open communication and constructive feedback.

Ensure Quality

Company is dedicated to ensuring the quality of its products and services. This value reflects the company's commitment to patient safety and product efficacy. Maintaining high-quality standards is essential for meeting regulatory requirements and building trust with healthcare professionals and patients.

Examples of how Company demonstrates this value include:

• Implementing quality control processes: Company has rigorous quality control processes in place to ensure the quality of its products. Company conducts regular inspections and audits of its manufacturing facilities.
• Monitoring product safety: Company actively monitors the safety of its products through post-market surveillance and adverse event reporting. Company has a dedicated team that monitors product safety data and takes action when necessary.
• Complying with regulatory requirements: Company complies with all applicable regulatory requirements, including those set by the FDA and EMA. Company has a team of regulatory affairs professionals who ensure compliance with laws and regulations.